Results for mpd translation from English to Estonian

mpd client
mpd klient

posology for mds/mpd
annustamine mds/mpd korral

a nicer mpd client
ilusam mpd klient

clinical studies in mds/mpd
kliinilised mds/mpd uuringud

mds/mpd (starting dose 400 mg)
mds/mpd (algannus 400 mg)

chronic phase cml, mds/ mpd and gist
kml krooniline faas, mds/ mpd ja gist (algannus 400 mg)

posology for mds/mpd in adult patients
annustamine täiskasvanutele mds/mpd korral

28 october 2005) and here (md/ mpd:
28. oktoober 2005), siit (müelodüsplastilised ja müeloproliferatiivsed haigused:

myelodysplastic/myeloproliferative diseases (mds/mpd).
müelodüsplastiliste/müeloproliferatiivsete haiguste (mds/mpd) ravis.

there are no controlled trials in paediatric patients with mds/mpd.
mds/mpd diagnoosiga lastel ei ole kontrollitud kliinilisi uuringuid läbi viidud.

chronic phase cml, mds/mpd (starting dose 400 mg)
kml krooniline faas, mds/mpd (algannus 400 mg)

in addition a further 24 patients with mds/mpd were reported in 13 publications.
lisaks sellele on 13 publikatsioonis teateid veel 24 mds/mpd patsiendi kohta.

this study included 7 patients with mds/mpd who were treated with glivec 400 mg daily.
selles uuringus osales 7 mds/mpd patsienti, keda raviti glivec’i annusega 400 mg ööpäevas.

the recommended dose of glivec is 400 mg/day for adult patients with mds/mpd.
glivec’i soovitatav annus mds/mpd täiskasvanud patsientidel on 400 mg/ööpäevas.

clinical studies in mds/ mpd experience with glivec in this indication is very limited and is based on haematological and cytogenetic response rates.
19 kliinilised mds/ mpd uuringud glivec’ i kasutamise kogemused sellel näidustusel on väga vähesed ning põhinevad hematoloogilise ja tsütogeneetilise ravivastuse määral.

posology for mds/ mpd the recommended dose of glivec is 400 mg/ day for patients with mds/ mpd.
annustamine mds/ mpd korral glivec' i soovitatav annus mds/ mpd patsientidel on 400 mg/ ööpäevas.

if you are being treated for mds/ mpd, the starting dose is 400 mg, to be taken as one tablet of 400 mg once a day.
kui teil ravitakse mds/ mpd, on algannus 400 mg, mis võetakse sisse ühe 400 mg tabletina üks kord päevas.

the experience with glivec in patients with mds/mpd associated with pdgfr gene re-arrangements is very limited (see section 5.1).
glivec’i kasutamise kogemused pdgfr geneetiliste muutustega mds/mpd patsientidel on väga vähesed (vt lõik 5.1).